MedPath

To determine the clinical efficacy and adverse effect of Platelet rich plasma in treatment of different types of striae.

Not Applicable
Conditions
Health Condition 1: L909- Atrophic disorder of skin, unspecified
Registration Number
CTRI/2021/10/037672
Lead Sponsor
Department of dermatology and venereology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Age group 18 -50 years

2. Striae of any type with bilateral distribution.

Exclusion Criteria

1.Not able give consent or understand protocol

2.Platelet disorder or anemia or malignacies

3.HIV or Hepatitis B or C patients.

4.Immunocompromised patients

5.Active skin disease or skin infection

6.On antiplatelet drugs or NSAIDS

Drugs or treatment in form of topical or oral for striae within past 6 months

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath